Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Kidney
Study Phase
Phase 3
Study Completion Date
2023-07-01
NCT01120249Uploaded 08-01-2024
Access via NCI by Request
PDS UID: nci-data-548
EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study
Provider Information
Provider Data DescriptionThis dataset contains the results reported in The Lancet (Ryan et al., The Lancet, 2023). The clinical dataset contains patient-level data (one row per patient), including, eligibility, evaluability, treatment, demographic, baseline information, and unblinding. It also contains assessment data. NCT01120249-D2 contains toxicity data.
SponsorSWOG Cancer Research Network
Data ProviderNational Cancer Institute
Clinical Trials.gov Information
Brief SummaryRATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the tumor. PURPOSE: This phase III trial is studying everolimus to see how well it works in treating patients with kidney cancer who have undergone surgery.
ConditionsKidney Cancer
Intervention TypeDrug: everolimus
Other: placebo
Drug(s)Drug: everolimus
Total Enrolled1545
RandomizationRandomized
Blinding MethodTriple
Arms InterventionArm I - Experimental
Arm II - Placebo Comparator
Secondary IDS0931
PubMed (PMID)N/A
Collaborator(s)National Cancer Institute (NCI)
Region(s)United States
Puerto Rico
Age Range18 Years to 120 Years (ADULT, OLDER_ADULT)
Files: NCT01120249-D1
Data DictionaryNCT01120249-D1-Data-Dictionary.pdf
DATANCT01120249-D1-Dataset.csv
OTHERREADME.pdf
Files: NCT01120249-D2
Data DictionaryNCT01120249-D2-Data-Dictionary.pdf
DATANCT01120249-D2-Dataset.csv
OTHERREADME.pdf
© 2024 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use